Improvement in Hyperglycemia Prevents Surgical Site Infection Irrespective of Insulin Therapy in Non-diabetic Patients Undergoing Gastrointestinal Surgery.
Ayami YonedaYoshio TakesueYoshiko TakahashiKaoru IchikiToshie TsuchidaHiroki IkeuchiMotoi UchinoEtsuro HatanoHisashi ShinoharaNaohiro TomitaPublished in: World journal of surgery (2021)
Remission of hyperglycemia within 24 h after surgery prevented SSI in non-diabetic patients. Considering that hyperglycemia improved in approximately half of patients without insulin therapy, commencement of insulin dosing after two consecutive BGs of ≥150 mg/dL might be reasonable, especially in general wards.
Keyphrases
- surgical site infection
- type diabetes
- patients undergoing
- end stage renal disease
- glycemic control
- ejection fraction
- newly diagnosed
- chronic kidney disease
- minimally invasive
- prognostic factors
- peritoneal dialysis
- stem cells
- metabolic syndrome
- patient reported outcomes
- bone marrow
- skeletal muscle
- weight loss
- wound healing
- patient reported